SKIN vs HELE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HELE Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Helen Of Troy Ltd (HELE) driven by superior Valuation, Growth & Margin, Options & Structure while SKIN counters with relative strength in Momentum & Technical. Fundamentally, SKIN trades at 106.4x Forward P/E with 2.4% operating margin (-2.1% YoY revenue) versus HELE at 11.5x Forward P/E and 5.5% operating margin (+2.1% YoY). In options structure, SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against HELE sits in BREAKOUT (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SKIN Revenue | HELE Revenue | SKIN Op. Margin | HELE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $170M | $1.56B | 8.1% | 12.7% | HELE |
| FY2020 | $120M | $1.71B | -14.4% | 10.4% | HELE |
| FY2021 | $260M | $2.10B | -15.4% | 13.4% | HELE |
| FY2022 | $370M | $2.22B | -7.1% | 12.3% | HELE |
| FY2023 | $400M | $2.07B | -32.9% | 10.2% | HELE |
| FY2024 | $330M | $2.01B | -20.3% | 13.0% | HELE |
| FY2025 | $300M | $1.91B | -6.9% | 7.5% | HELE |
| FY2026 | N/A | $1.79B | N/A | -43.8% | HELE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SKIN | HELE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $106.3M | $872.9M | Larger Scale | HELE |
| Trailing P/E Ratio Valuation | 106.4x | 9.2x | Lower Multiple | HELE |
| Forward P/E Ratio Valuation | 106.4x | 11.5x | Lower Multiple | HELE |
| Revenue Growth (YoY) Growth | -2.1% | +2.1% | Higher Growth | HELE |
| Operating Margin (TTM) Profitability | 2.4% | 5.5% | Higher Margin | HELE |
| Net Profit Margin Profitability | -6.3% | -5.4% | Higher Margin | HELE |
| Return on Equity (ROE) Capital Efficiency | -30.1% | -11.2% | Higher ROE | HELE |
| 52-Week Range Position Momentum | 83% ($0โ$18) | 94% ($14โ$39) | Stronger Trend | HELE |
| Beta / 30D Volatility Risk Regime | -14.22ฮฒ ยท 192% Vol | 0.81ฮฒ ยท 93% Vol | Lower Realized Risk | HELE |
| Unified Institutional Score Composite Signal | 34.1 / 100 (SELL) | 31.0 / 100 (SELL) | Higher Composite | SKIN |